These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 28536304)
21. Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice. Irimia JM; Tagliabracci VS; Meyer CM; Segvich DM; DePaoli-Roach AA; Roach PJ J Biol Chem; 2015 Sep; 290(37):22686-98. PubMed ID: 26216881 [TBL] [Abstract][Full Text] [Related]
22. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex. Rubio-Villena C; Garcia-Gimeno MA; Sanz P Int J Biochem Cell Biol; 2013 Jul; 45(7):1479-88. PubMed ID: 23624058 [TBL] [Abstract][Full Text] [Related]
24. FoxO3a-mediated autophagy is down-regulated in the laforin deficient mice, an animal model for Lafora progressive myoclonus epilepsy. Jain N; Mishra R; Ganesh S Biochem Biophys Res Commun; 2016 May; 474(2):321-327. PubMed ID: 27107699 [TBL] [Abstract][Full Text] [Related]
25. Malin knockout mice support a primary role of autophagy in the pathogenesis of Lafora disease. Knecht E; Criado-García O; Aguado C; Gayarre J; Duran-Trio L; Garcia-Cabrero AM; Vernia S; San Millán B; Heredia M; Romá-Mateo C; Mouron S; Juana-López L; Domínguez M; Navarro C; Serratosa JM; Sanchez M; Sanz P; Bovolenta P; Rodríguez de Córdoba S Autophagy; 2012 Apr; 8(4):701-3. PubMed ID: 22361617 [TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan. Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070 [TBL] [Abstract][Full Text] [Related]
27. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Gentry MS; Worby CA; Dixon JE Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137 [TBL] [Abstract][Full Text] [Related]
28. Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease. Singh PK; Singh S; Ganesh S Mol Biol Cell; 2013 Dec; 24(24):3776-86. PubMed ID: 24131995 [TBL] [Abstract][Full Text] [Related]
29. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway. Upadhyay M; Gupta S; Bhadauriya P; Ganesh S Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034 [TBL] [Abstract][Full Text] [Related]
30. Deciphering the role of malin in the lafora progressive myoclonus epilepsy. Romá-Mateo C; Sanz P; Gentry MS IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-Cage Behavior. Krishnan V; Wu J; Mazumder AG; Kamen JL; Schirmer C; Adhyapak N; Bass JS; Lee SC; Maheshwari A; Molinaro G; Gibson JR; Huber KM; Minassian BA J Comp Neurol; 2024 Jul; 532(7):e25660. PubMed ID: 39039998 [TBL] [Abstract][Full Text] [Related]
32. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters. Singh PK; Singh S; Ganesh S Mol Cell Biol; 2012 Feb; 32(3):652-63. PubMed ID: 22124153 [TBL] [Abstract][Full Text] [Related]
33. Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease. Puri R; Suzuki T; Yamakawa K; Ganesh S Hum Mol Genet; 2012 Jan; 21(1):175-84. PubMed ID: 21965301 [TBL] [Abstract][Full Text] [Related]
34. Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease. Rai A; Mishra R; Ganesh S Hum Mol Genet; 2017 Dec; 26(24):4778-4785. PubMed ID: 28973665 [TBL] [Abstract][Full Text] [Related]
35. Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. Gentry MS; Romá-Mateo C; Sanz P FEBS J; 2013 Jan; 280(2):525-37. PubMed ID: 22364389 [TBL] [Abstract][Full Text] [Related]
36. Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease. Puri R; Suzuki T; Yamakawa K; Ganesh S J Biol Chem; 2009 Aug; 284(34):22657-63. PubMed ID: 19542233 [TBL] [Abstract][Full Text] [Related]
37. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. Dukhande VV; Rogers DM; Romá-Mateo C; Donderis J; Marina A; Taylor AO; Sanz P; Gentry MS PLoS One; 2011; 6(8):e24040. PubMed ID: 21887368 [TBL] [Abstract][Full Text] [Related]
38. Protein degradation and quality control in cells from laforin and malin knockout mice. Garyali P; Segvich DM; DePaoli-Roach AA; Roach PJ J Biol Chem; 2014 Jul; 289(30):20606-14. PubMed ID: 24914213 [TBL] [Abstract][Full Text] [Related]
39. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Tagliabracci VS; Turnbull J; Wang W; Girard JM; Zhao X; Skurat AV; Delgado-Escueta AV; Minassian BA; Depaoli-Roach AA; Roach PJ Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19262-6. PubMed ID: 18040046 [TBL] [Abstract][Full Text] [Related]